[vc_column align=”hook_left_align” col_width=”80″ css_animation=”right-to-left-faster” css_delay=”90″][prkwp_spacer size=”108″][prkwp_service name=”MORSE Consulting delivers training sessions on the Canadian pharmaceutical reimbursement environment that can be customized for various target audiences.” text_color=”#13294b” icon_type=”custom_image” align=”center”][prkwp_spacer size=”108″][/vc_column]
Manufacturer’s market access lead faced issues in sensitizing the Executive Leadership Team (ELT) on the challenges associated with the reimbursement environment in Canada.
Developed a training session that provided an overview and description of the “current state” of the Canadian current market access environment to the ELT. Leveraged direct experience and pan-Canadian Pharmaceutical Alliance (pCPA) process metrics to help manage ELT expectations in terms of time-to-negotiate, level of value typically sought in pCPA negotiations, and the potential for variation in the level of public reimbursement between provinces. Through a comprehensive interactive session, began to sensitize ELT to the importance of timely global engagement and support for market access strategies and negotiation mandates.
[/vc_column_text][prkwp_service name=”Value to Client” text_color=”#43a7c6″ icon_type=”custom_image” align=”center” text_align=”hook_left_align” icon_up_color=”#13294b”][vc_column_text]
The training session sensitized the ELT to the rapidly changing and challenging reimbursement environment and “level-set” internal expectations for current and upcoming launches.
